Yeji
NDA/BLA filedconf 0.95

axs-07 — NDA/BLA filed

$AXSM · Axsome Therapeutics, Inc. · acute treatment of migraine
Event date
September 14, 2021
1726 days ago
Sponsor runway
44 mo
$305.1M liquid

Evidence

“the U.S. Food and Drug Administration (FDA) has accepted for filing the Company\'s New Drug Application (NDA) for AXS-07 for the acute treatment of migraine”
Source: Press release · 2021-09-14View press release ↗

Comparable historical nda/bla fileds· last 5 years · same indication

TickerDrugDateOutcome
$AXSMaxs-072024-09-04unknown

Recent insider activity· ±90 days

5 insiders · 9 buys · 0 sells
Buy
2021-11-19
JEFFS ROGER
Director
3,950 @ $37.30$147K
Buy
2021-11-18
Pizzie Nick
Chief Financial Officer
527 @ $35.50$19K
Buy
2021-11-18
Coleman Mark
Director
409 @ $35.07$14K
Buy
2021-11-18
Pizzie Nick
Chief Financial Officer
145 @ $34.30$5K
Buy
2021-11-18
Pizzie Nick
Chief Financial Officer
142 @ $35.20$5K
Buy
2021-11-18
Coleman Mark
Director
1,021 @ $35.10$36K
Buy
2021-11-18
Pizzie Nick
Chief Financial Officer
141 @ $35.43$5K
Buy
2021-11-17
Saad Mark E
Director
100 @ $34.40$3K
Buy
2021-11-17
Saad Mark E
Director
3,000 @ $34.53$104K
Grant
2021-11-12
Jacobson Mark L.
Chief Operating Officer
41,638 @ ——
Grant
2021-11-12
Pizzie Nick
Chief Financial Officer
36,086 @ ——
← All catalysts for $AXSM